Ukr.Biochem.J. 2015; Volume 87, Issue 5, Sep-Oct, pp. 83-92


The search of compounds with antiaggregation activity among S-esters of thiosulfonic acids

T. I. Halenova1, I. V. Nikolaeva1, A. V. Nakonechna2,
K. B. Bolibrukh2, N. Y. Monka2, V. I. Lubenets2,
O. M. Savchuk1, V. P. Novikov2, L. I. Ostapchenko1

1Educational and Scientific Centre “Institute of Biology”,
Taras Shevchenko National University of Kyiv, Ukraine;
2Lviv Polytechnic National University, Ukraine;

According to the current understanding, the hyperactivation of platelets may lead to increased intravascular coagulation and thrombosis. Today a relevant issue is the search for new anti-thrombotic agents that are able to modulate the activity of platelet receptors, thus, influence the processes of activation and aggregation of platelets. The aim of this study was to investigate the effects of newly synthesized thiosulfonate derivatives on platelet aggregation. The activity of the compounds was tested in vitro using platelet-rich plasma. As a result of the screening test, structural formulas of four agents with high antiaggregative activity were established. These compounds inhibited ADP- and collagen-induced platelet aggregation in a dose-dependent manner. Two of these compounds were shown to be more effective inhibitors of aggregation induced by ADP (IC50 ~ 8-10 µM), as well as collagen (IC50 ~ 1.5-2.0 µM).

Keywords: , , , ,


  1. ISTH Steering Committee for World Thrombosis Day. Thrombosis: a major contributor to the global disease burden. J Thromb Haemost. 2014 Oct;12(10):1580-90. Review. PubMed, CrossRef
  2. Furie B, Furie BC. Mechanisms of thrombus formation. N Engl J Med. 2008 Aug 28;359(9):938-49. Review. PubMed, CrossRef
  3. Munnix IC, Cosemans JM, Auger JM, Heemskerk JW. Platelet response heterogeneity in thrombus formation. Thromb Haemost. 2009 Dec;102(6):1149-56. Review. PubMed, CrossRef
  4. Robless PA, Okonko D, Lintott P, Mansfield AO, Mikhailidis DP, Stansby GP. Increased platelet aggregation and activation in peripheral arterial disease. Eur J Vasc Endovasc Surg. 2003 Jan;25(1):16-22. PubMed,   CrossRef
  5.   Broos K, Feys HB, De Meyer SF, Vanhoorelbeke K, Deckmyn H. Platelets at work in primary hemostasis. Blood Rev. 2011 Jul;25(4):155-67. Review. PubMed, CrossRef
  6. Wagner DD, Burger PC. Platelets in inflammation and thrombosis. Arterioscler Thromb Vasc Biol. 2003 Dec;23(12):2131-7. Review. PubMedCrossRef
  7. Freedman JE. Molecular regulation of platelet-dependent thrombosis. Circulation. 2005 Oct 25;112(17):2725-34. PubMedCrossRef
  8. Ji X, Hou M. Novel agents for anti-platelet therapy. J Hematol Oncol. 2011 Nov 4;4:44. Review. PubMed, PubMedCentral, CrossRef
  9. Bolibrukh K, Polovkovych S, Khoumeri O, Halenova T, Nikolaeva I, Savchuk O, Terme T, Vanelle P, Lubenets V, Novikov V. Synthesis and anti-platelet activity of thiosulfonate derivatives containing a quinone moiety. Sci Pharm. 2015;83:221-231. CrossRef
  10.  Block E, Shu-Hai Zhao. Allium chemistry: simple synthesis of antithrombotic cepaenes from onion and deoxycepaenes from oil of shallot by reaction 1-propenethiolate with sulfonyl halides. J Org Chem. 1992;57(22):5815-5817. CrossRef
  11.  Martelli A, Testai L, Marino A, Breschi MC, Da Settimo F, Calderone V. Hydrogen sulphide: biopharmacological roles in the cardiovascular system and pharmaceutical perspectives. Curr Med Chem. 2012;19(20):3325-36. Review. PubMed, CrossRef
  12. Takada N, Watanabe M, Suenaga K, Yamada K, Kita M, Uemura D. Isolation and structures of hedathiosulfonic acids A and B, novel thiosulfonic acids from the deep-sea urchin Echinocardium cordatum. Tetrahedron Lett. 2001 Sep;42(37):6557-6560. CrossRef
  13. Lubenets V, Karpenko O, Ponomarenko M, Zahoriy G, Krychkovska A, Novikov V. Development of new antimicrobial compositions of thiosulfonate structure. Chem Chem Technol. 2013;7:119-124.
  14. Mon’ka NYa, Vasylyuk SV, Lubenets VI, Kovalenko SI, Novikov VP. Reaction of 4-chloroquinazoline with arenesulfonothioic acid salts. Russ J Org Chem. 2013;49(12):1857-1858. CrossRef
  15. Asmis L, Tanner FC, Sudano I, Lüscher TF, Camici GG. DMSO inhibits human platelet activation through cyclooxygenase-1 inhibition. A novel agent for drug eluting stents? Biochem Biophys Res Commun. 2010 Jan 22;391(4):1629-33. PubMed, CrossRef
  16. Floyd CN, Passacquale G, Ferro A. Comparative pharmacokinetics and pharmacodynamics of platelet adenosine diphosphate receptor antagonists and their clinical implications. Clin Pharmacokinet. 2012 Jul 1;51(7):429-42. Review. PubMed, CrossRef
  17. Alexopoulos D. p2y12 receptor inhibitors in acute coronary syndromes: from the research laboratory to the clinic and vice versa. Cardiology. 2014;127(4):211-9. Review. PubMed, CrossRef
  18. MacDonald JA, Marchand ME, Langler RF. Improving upon the in vitro biological activity of antithrombotic disulfides. Blood Coagul Fibrinolysis. 2004 Sep;15(6):447-50. PubMedCrossRef
  19. MacDonald JA, Langler RF. Structure-activity relationships for selected sulfur-rich antithrombotic compounds. Biochem Biophys Res Commun. 2000 Jul 5;273(2):421-4. PubMedCrossRef

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License.